Axe Compute Inc. logo

AGPUAxe Compute Inc.

NASDAQ · Technology · Software - Infrastructure

$9.89

+$0.44 (+4.70%)

Axe Compute Inc. (AGPU) is a software - infrastructure company listed on NASDAQ. It is led by Christopher Miglino, based in 91 43rd Street, Pittsburgh, PA, United States, 15201, with about 13 employees. Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services. The Compute Services and Treasury Management segment provides access to graphics processing unit compute capacity and digital asset treasury strategy focused on Aethir token. The Drug Discovery Services segment engages in the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.

Net income was -$77.7M. AGPU currently screens at market cap $76.3M.

Use this AGPU page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AGPU quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AGPU SEC filings page. Lician reads the product cache first so this HTML stays unique to Axe Compute Inc. even when a live quote feed is slow.

About Axe Compute Inc.

Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services. The Compute Services and Treasury Management segment provides access to graphics processing unit compute capacity and digital asset treasury strategy focused on Aethir token. The Drug Discovery Services segment engages in the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.

AGPU Key Statistics

Market Cap

$76.29M

Volume

236,074

Previous Close

$10.27

Day Range

$10.11$10.57

0

P/B Ratio

2.00

EPS

$0.00

Revenue

$0.00

Net Income

-$12.66M

Gross Profit

$0.00

Free Cash Flow

$0.00

Employees

13

AGPU Financials

Annual income statement in USD. Latest reported periods first.

AGPU annual income statement across FY2024, FY2023, FY2022, FY2021
LineFY2024FY2023FY2022FY2021
Revenue$0.00$0.00$0.00$0.00
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00$0.00
Net Income-$12.66M-$13.98M-$25.74M-$19.66M
EPS (Diluted)$0.00$0.00$0.00$0.00

Total Assets

$4.97M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$734.67K

Operating Cash Flow

-$13.19M

Free Cash Flow

$0.00

Axe Compute Inc. Company Information

CEO & Director
Christopher Miglino
Headquarters
91 43rd Street, Pittsburgh, PA, United States, 15201
Phone
412 432 1500
IPO / Founded
2018-01-29
Industry
Software - Infrastructure
Data Updated:

Upcoming Events for AGPU